Cover Image

On "New Cardiovascular Drugs: Patterns of Use and Association with Non-Drug Health Expenditures"

Saved in:

Bibliographic Details
Main Author:	Frank R. Lichtenberg Ph.D (Author)
Format:	Book
Published:	SAGE Publishing, 2006-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New Cardiovascular Drugs: Patterns of Use and Association with Non-Drug Health Expenditures
by: G. Edward Miller, et al.
Published: (2005)

The impact of cardiovascular drug innovation on the longevity of elderly residents of Switzerland, 2003-2012
by: Frank R Lichtenberg
Published: (2015)

Number of drugs provided by the Pharmaceutical Benefits Scheme and mortality and hospital utilization in Australia, 2002-2019
by: Frank R. Lichtenberg
Published: (2023)

Do newer drugs treat fewer diseases, controlling for time since launch? Evidence from France and the U.S.
by: Frank R. Lichtenberg
Published: (2024)

Drugs with the highest drug expenditure in the Republic of Serbia
by: Milijašević Boris Ž., et al.
Published: (2023)

Drug utilization and expenditure of anticancer drugs for breast cancer
by: Bander Balkhi, et al.
Published: (2020)

The influences of Taiwan's generic grouping price policy on drug prices and expenditures: Evidence from analysing the consumption of the three most-used classes of cardiovascular drugs
by: Chen Likwang, et al.
Published: (2008)

Medicare Expenditures Associated With Hospital and Emergency Department Use Among Beneficiaries With Dementia
by: Laura Coots Daras MS, MA, et al.
Published: (2017)

Using spatial analysis to demonstrate the heterogeneity of the cardiovascular drug-prescribing pattern in Taiwan
by: Liu Tzu-Ming, et al.
Published: (2011)

Basic patterns in national health expenditure
by: Musgrove Philip, et al.
Published: (2002)

Forecasting drug utilization and expenditure in a metropolitan health region
by: Korkmaz Seher, et al.
Published: (2010)

Merger & Acquisition and Capital Expenditure in Health Care
by: Wenjing Ouyang PhD, et al.
Published: (2017)

A new initiative on primary and preventive health care-early results on expenditure patterns
by: Vedam Shankar
Published: (2007)

Targeting Energy Expenditure-Drugs for Obesity Treatment
by: Carlos M. Jimenez-Munoz, et al.
Published: (2021)

Consequences of Information and Communication Technologies and Environmental Degradation on Health Expenditure
by: Yuksel Bayraktar PhD, et al.
Published: (2024)

Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular disease
by: Blake Angell, et al.
Published: (2017)

Classification of drug use patterns
by: Christiaan H. Righolt, et al.
Published: (2020)

The impact of biomedical innovation on longevity and health
by: Frank R Lichtenberg
Published: (2015)

Determinants of drug expenditure in the Swiss healthcare market in 2006
by: Yves Eggli, et al.
Published: (2022)

Health Expenditure Concentration and Characteristics of High-Cost Enrollees in CHIP
by: Bisakha Sen PhD, et al.
Published: (2016)

Health Care Expenditure Burden of Cancer Care in the United States
by: Joohyun Park PhD, et al.
Published: (2019)

Expenditure of biological drugs for rheumatoid arthritis treatment in the Brazilian public health system
by: Tacila Pires Mega, et al.
Published: (2023)

EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS
by: I. A. Skripnikova, et al.
Published: (2015)

EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS
by: I. A. Skripnikova, et al.
Published: (2015)

Drug use trajectory patterns among older drug users
by: Tyndall B, et al.
Published: (2011)

Paclitaxel: new uses for an old drug
by: Zhang D, et al.
Published: (2014)

Catastrophic Health Expenditure before and after of the Implementation of Health Sector Evolution Plan in Iran
by: Razieh Ahmadi MSc, et al.
Published: (2021)

The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis
by: Gedik H
Published: (2015)

Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
by: Mart A.F.J. van de Laar, et al.
Published: (2010)

Expenditure trends of orphan drugs in Serbia: 8-Year analysis of orphan drug market in Serbia
by: Pejčić Ana V., et al.
Published: (2016)

Regional pattern of child undernutrition, calorie consumption, non-food expenditure and wealth in India
by: Junaid Khan, et al.
Published: (2022)

Forecasting drug utilization and expenditure: ten years of experience in Stockholm
by: Love Linnér, et al.
Published: (2020)

Cross-border Activities Associated With Pattern of Amphetamine-type Stimulants Usage Among Drug Users in Southwest of China
by: Mingmei Zhang Master, et al.
Published: (2023)

Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data
by: Yang Zhao, PhD, et al.
Published: (2020)

Associations of Atrial Fibrillation Patterns With Mortality and Cardiovascular Events: Implications of the MISOAC-AF Trial
by: Amalia Baroutidou MD, et al.
Published: (2022)

New non-drug technologies for lymphedema associated with breast cancer: a review
by: Tatiana V. Apkhanova, et al.
Published: (2024)

A Copayment Increase for Prescription Drugs: The Long-Term and Short-Term Effects on Use and Expenditures
by: Teresa B. Gibson, et al.
Published: (2005)

Association between non-pharmacological therapy and healthcare use and expenditure of patients with diabetes mellitus
by: Abdullah Alfaifi
Published: (2023)

Premature mortality from cardiovascular disease and diabetes in the Caribbean and associations with health care expenditure, 2001 − 2011
by: Ahmed Razavi, et al.
Published: (2018)

Cardiovascular drugs and erectile dysfunction
by: Terzić Branka M., et al.
Published: (2014)